RFK Jr. Faces Democratic Pushback as HHS Navigates Key Health Appointments
Recent coverage highlights significant political and administrative developments within the U.S. Department of Health and Human Services (HHS) under Secretary Robert F. Kennedy Jr. Kennedy recently faced intense scrutiny and a barrage of questions from Democrats during House hearings, reflecting diminished political clout as he returns to Capitol Hill. Concurrently, the Trump administration is moving to fill critical health leadership roles, with former deputy surgeon general nominated to lead the Centers for Disease Control and Prevention (CDC) after previous delays. Inside HHS, new initiatives include the appointment of an affordability czar to address healthcare costs. The broader health policy landscape features ongoing legal battles, such as AbbVie’s lawsuit regarding drug discount definitions, and state-level regulatory changes like California’s folic acid rule affecting tortilla production and birth defect risks. These events underscore the administration's efforts to reshape public health policy, vaccine injury compensation frameworks, and drug pricing mechanisms amidst partisan tension and organizational restructuring.
Wire timeline
RFK Jr. Faces Democratic Pushback as HHS Navigates Key Health Appointments
Recent coverage highlights significant political and administrative developments within the U.S. Department of Health and Human Services (HHS) under Secretary Robert F. Kennedy Jr. Kennedy recently faced intense scrutiny and a barrage of questions from Democrats during House hearings, reflecting diminished political clout as he returns to Capitol Hill. Concurrently, the Trump administration is moving to fill critical health leadership roles, with former deputy surgeon general nominated to lead the Centers for Disease Control and Prevention (CDC) after previous delays. Inside HHS, new initiatives include the appointment of an affordability czar to address healthcare costs. The broader health policy landscape features ongoing legal battles, such as AbbVie’s lawsuit regarding drug discount definitions, and state-level regulatory changes like California’s folic acid rule affecting tortilla production and birth defect risks. These events underscore the administration's efforts to reshape public health policy, vaccine injury compensation frameworks, and drug pricing mechanisms amidst partisan tension and organizational restructuring.
axios